Novo to Launch Once-a-Day Insulin Injection Tresiba in India

by Kathy Jones on  September 3, 2013 at 9:39 PM Diabetes News
RSS Email Print This Page Comment
Font : A-A+

Danish drugmaker Novo Nordisk revealed that it will soon be launching its long-lasting insulin injection, Tresiba, in India for type 1 and type 2 diabetes patients.
 Novo to Launch Once-a-Day Insulin Injection Tresiba in India
Novo to Launch Once-a-Day Insulin Injection Tresiba in India

The once-a-day jab can provide insulin action for up to 42 hours, allowing diabetics to day-to-day dosing time when needed without raising the risk of hypoglycaemia. The injection will come in form of a prefilled pen and can enable a dosage of up to 80 units in a single use. The company said that it will be revealing the pricing for Tresiba at the time of its launch.

"Tresiba (insulin degludec)-- a new basal insulin for adult patients with type 1 and type 2 diabetes to be available in India as a new treatment option. We are through with clinical trials and have received the necessary approvals. We hope to launch it by the end of this year", Novo Nordisk India Managing Director Melvin D'souza said.



Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Diabetes - Essentials Gestational diabetes Type 2 Diabetes Diabetes - Foot Care Diabesity Diabetes in Pets Diabetes Facts and Figures Insulin Hormone Hypoglycemia (Low Blood Sugar) Modified Atkins Diet: All You Need to Know 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive